首页> 美国卫生研究院文献>Case Reports in Pediatrics >Late Onset Cobalamin Disorder and Hemolytic Uremic Syndrome: A Rare Cause of Nephrotic Syndrome
【2h】

Late Onset Cobalamin Disorder and Hemolytic Uremic Syndrome: A Rare Cause of Nephrotic Syndrome

机译:迟发性钴胺素症和溶血性尿毒症综合征:肾病综合征的罕见原因。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Hemolytic uremic syndrome (HUS) is an unrare and severe thrombotic microangiopathy (TMA) caused by several pathogenetic mechanisms among which Shiga toxin-producing Escherichia coli infections and complement dysregulation are the most common. However, very rarely and particularly in neonates and infants, disorders of cobalamin metabolism (CblC) can present with or be complicated by TMA. Herein we describe a case of atypical HUS (aHUS) related to CblC disease which first presented in a previously healthy boy at age of 13.6 years. The clinical picture was initially dominated by nephrotic range proteinuria and severe hypertension followed by renal failure. The specific treatment with high dose of hydroxycobalamin rapidly obtained the remission of TMA and the complete recovery of renal function. We conclude that plasma homocysteine and methionine determinations together with urine organic acid analysis should be included in the diagnostic work-up of any patient with TMA and/or nephrotic syndrome regardless of age.
机译:溶血性尿毒症综合征(HUS)是一种罕见的严重血栓性微血管病(TMA),由多种致病机制引起,其中最常见的是产生志贺毒素的大肠杆菌感染和补体调节异常。但是,很少发生,特别是在新生儿和婴儿中,钴胺素代谢紊乱(CblC)可能伴有TMA或由TMA并发。在本文中,我们描述了一例与CblC疾病有关的非典型HUS(aHUS),该病例首先出现在一个13.6岁的先前健康的男孩中。临床表现最初主要由肾病范围蛋白尿和严重高血压继之以肾衰竭。高剂量羟钴胺素的特异性治疗可迅速缓解TMA,并完全恢复肾功能。我们得出的结论是,无论年龄大小,任何患有TMA和/或肾病综合征的患者的诊断检查均应包括血浆高半胱氨酸和蛋氨酸的测定以及尿液有机酸的分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号